HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Procter & Gamble

This article was originally published in The Rose Sheet

Executive Summary

Global technology of aculyn 44 and 46 licensed to International Specialty Products for use in hair and skin care products under nine-year agreement announced March 12. Thickening agents are marketed by ISP and produced by Rohm & Haas under their personal care strategic/marketing alliance. ISP gains worldwide distribution rights for use of the P&G technologies across all trade channels, firm says. Technology licensing is part of P&G strategy to increase shareholder value. Procter uses only 10% of its 27,000 technologies created in its $2 bil. R&D department. Additional licensing deals with competitors under consideration, consumer goods firm says. P&G plans to make thousands of technologies available for licensing worldwide (1"The Rose Sheet" Oct. 9, 2000, p. 12)
Advertisement

Related Content

P&G Shaving Products Licensing Agreement To Enhance Noxzema, Old Spice
P&G Takes "Gamble" Out Of Stock Price, Shares Jump 17% In Third Quarter
P&G Takes "Gamble" Out Of Stock Price, Shares Jump 17% In Third Quarter
Advertisement
UsernamePublicRestriction

Register

RS009044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel